Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the Elderly

Clinical trial NCT05283902 · COMPLETED

Trial details

NCT number: NCT05283902
Sponsor: Federal University of Espirito Santo
Status: COMPLETED
Study type: OBSERVATIONAL

COVID-19 Vaccine Adverse Reaction Vaccine-Preventable Diseases

Start date: 2022-03-19
Primary completion: 2022-06-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.